QV Bioelectronics
World-first implantable brain cancer therapy
- Headquarters
- Alderley Park
- Founded
- 2018
- Business Model
- B2B
- Website
- qvbio.co.uk
- Total Funding
- $7.7M
- Last Round
- $5.6M Series AJan 2026
About
VC-backed medical device startup developing GRACE (Glioma Resection Advanced Cavity Electric Field Therapy), an implantable electric field therapy device to treat glioblastoma (aggressive brain tumors). Device delivers continuous therapeutic electric fields to surgical cavity post-resection. Founders: Dr Christopher Bullock (CEO, biomedical engineer) and Dr Richard Fu (neurosurgeon).
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account